This compound is an Fmoc-protected, N-methylated derivative of L-leucine, used as a building block in solid-phase peptide synthesis. Its structure incorporates a fluorenylmethoxycarbonyl (Fmoc) group for temporary protection of the amino function, enabling the sequential assembly of peptides.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 103478-62-2
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-N-methyl-L-alanine
Peptide synthesis building block
N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methyl-L-isoleucine
Fmoc-protected amino acid for peptide synthesis
FMoc-alpha-Me-D-Phe(2-F)-OH
Fmoc-protected amino acid for peptide synthesis
Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH
Fmoc-protected amino acid for peptide synthesis
Fmoc-L-Propargylglycine
Fmoc-protected amino acid for peptide synthesis
2-Amino-4-(4-methylpiperazin-1-yl) benzoic acid tertbutyl ester
Pharmaceutical intermediate
4-(4-Methylpiperazin-1-yl)-2-(2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido)benzoic acid 2,2,2-trifluoroacetate
pharmaceutical intermediate
Benzyl (1-(hydroxymethyl)cyclopropyl)carbamate
peptide synthesis protecting reagent
(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-4-methylpentanoic acid
BUJQSIPFDWLNDC-FQEVSTJZSA-N
CC(C)C[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13